AMPLATZER Patent Foramen Ovale (PFO) Occluder Post Approval Study (PFO PAS)
Principal Investigator
David WoodOverview
Body Locations and Systems
HeartDiagnosis and Therapy
Heart SurgeryDisorders and Conditions
Congenital Heart DefectsClinicalTrials.gov#
NCT03309332Status
RecruitingStudy Start/End
Jul 8, 2019 to Dec 31, 2020Locations
Diamond Health Care CentreName/Title
Brady Robinson, Research CoordinatorPhone
604-875-5106Email Address
brady.robinson@vch.caPurpose of Study
The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ Patent Foramen Ovale (PFO) Occluder in the post Approval Setting.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.